<VariationArchive VariationID="8921" VariationName="NM_000891.3(KCNJ2):c.285_296del (p.Trp96_Phe99del)" VariationType="Deletion" Accession="VCV000008921" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2013-04-04" MostRecentSubmission="2024-05-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23960" VariationID="8921">
      <GeneList>
        <Gene Symbol="KCNJ2" FullName="potassium inwardly rectifying channel subfamily J member 2" GeneID="3759" HGNC_ID="HGNC:6263" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70169532" stop="70180044" display_start="70169532" display_stop="70180044" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68165675" stop="68176184" display_start="68165675" display_stop="68176184" Strand="+" />
          </Location>
          <OMIM>600681</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000891.3(KCNJ2):c.285_296del (p.Trp96_Phe99del)</Name>
      <CanonicalSPDI>NC_000017.11:70175323:ATGGCTGTTTTT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70175324" stop="70175335" display_start="70175324" display_stop="70175335" variantLength="12" positionVCF="70175323" referenceAlleleVCF="CATGGCTGTTTTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68171465" stop="68171476" display_start="68171465" display_stop="68171476" variantLength="12" positionVCF="68171464" referenceAlleleVCF="CATGGCTGTTTTT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.68171465_68171476del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.68171465_68171476del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.70175324_70175335del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.70175324_70175335del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008798.1" sequenceAccession="NG_008798" sequenceVersion="1" change="g.10790_10801del">
            <Expression>NG_008798.1:g.10790_10801del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000891.3" sequenceAccession="NM_000891" sequenceVersion="3" change="c.285_296del" MANESelect="true">
            <Expression>NM_000891.3:c.285_296del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000882.1" sequenceAccession="NP_000882" sequenceVersion="1" change="p.Trp96_Phe99del">
            <Expression>NP_000882.1:p.Trp96_Phe99del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_328" sequenceAccession="LRG_328">
            <Expression>LRG_328:g.10790_10801del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600681.0004" DB="OMIM" />
        <XRef Type="rs" ID="2144376746" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000891.3(KCNJ2):c.285_296del (p.Trp96_Phe99del) AND Andersen Tawil syndrome" Accession="RCV000009476" Version="6">
        <ClassifiedConditionList TraitSetID="2458">
          <ClassifiedCondition DB="MedGen" ID="C1563715">Andersen Tawil syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-05-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-05-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-05-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11371347</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2458" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="244" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Andersen Tawil syndrome</ElementValue>
                <XRef ID="Andersen+Tawil+Syndrome/431" DB="Genetic Alliance" />
                <XRef ID="422348008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen cardiodysrhythmic periodic paralysis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic paralysis, potassium-sensitive cardiodysrhythmic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LQT7</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9453" />
                <XRef ID="9453" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described.</Attribute>
                <XRef ID="NBK1264" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301441</ID>
                <ID Source="BookShelf">NBK1264</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="37553" DB="Orphanet" />
              <XRef ID="C1563715" DB="MedGen" />
              <XRef ID="MONDO:0008222" DB="MONDO" />
              <XRef Type="MIM" ID="170390" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29694" SubmissionDate="2012-09-26" DateLastUpdated="2024-05-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600681.0004_ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS" title="KCNJ2, 12-BP DEL, NT513_ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS" />
        <ClinVarAccession Accession="SCV000029694" DateUpdated="2024-05-07" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-05-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an affected individual of a pedigree (K2281) with Andersen syndrome (170390), Plaster et al. (2001) identified a heterozygous (dominant) in-frame deletion of 12 nucleotides in the KCNJ2 gene, resulting in the deletion of amino acids 95 to 98 in the M1 transmembrane segment. This mutation was not found in 100 unaffected and unrelated individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">11371347</ID>
              </Citation>
              <XRef DB="OMIM" ID="170390" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNJ2" />
          </GeneList>
          <Name>KCNJ2, 12-BP DEL, NT513</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">12-BP DEL, NT513</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600681.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29694" TraitType="Disease" MappingType="Name" MappingValue="ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS" MappingRef="Preferred">
        <MedGen CUI="C1563715" Name="Andersen Tawil syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

